HOME >> BIOLOGY >> NEWS
Nation's plant database falling behind, survey shows

EAST LANSING, Mich. Stopping to smell the roses may be laudable, but more people need to be picking, preserving and cataloging them.

Smelling doesn't build and maintain a rich and necessary documentation of the nation's biodiversity. A drop-off in collecting plants threatens the flora database that is the primary source of material for gardeners, county extension agents, nature enthusiasts, artists and illustrators as well as for medical scientists, forensics experts, law enforcement agencies and other scientists.

The problem: Collecting local or in-state plant life is in steep decline, at a time when habitat is changing dramatically.

"To protect the best remaining native forests, and to determine how development can best reflect our values, we have to thoroughly understand our natural heritage" said Alan Prather, a botanist and plant curator at Michigan State University. "This information has to be kept current, because new invasive species are introduced every year and once-pristine habitats are destroyed by both natural and human forces."

Prather and Carolyn Ferguson of Kansas State University have outlined the trend toward doing less collecting which holds true from the vast holdings of the Field Museum in Chicago to smaller plant museums that house only a few thousand specimens.

Their article, "The Decline of Plant Collecting in the United States: A Threat to the Infrastructure of Biodiversity Studies," and the accompanying "Commentary: Implications of the Decline in Plant Collecting for Systematic and Floristic Research" appear in the spring 2004 issue of Systematic Botany.

The researchers surveyed small and large collections of plants or herbaria, from public and private institutions, universities, museums and botanical gardens, and from 30 states and the District of Columbia.

Their findings are startling: Fewer scientists and
'"/>

Contact: Alan Prather
alan@msu.edu
202-357-4808
Michigan State University
7-Jun-2004


Page: 1 2

Related biology news :

1. ASM Calls For Focus On Microbial Pollution Of Nations Water Supply
2. Nations Leading Biomedical Researchers Present Breakthroughs in Liver Disease
3. Carnegie Mellon Researchers Develop Nations First Robotic Tour Guide For The Dinosaur Hall At Pittsburghs Carnegie Museum Of Natural History
4. Research Aims At Nations First Smart Ground Water Regulations
5. Pack-MULEs are toting a new look at plant evolution
6. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
7. Pollutant causes delayed flowering in plants
8. NSF awards 22 new projects for plant genome research
9. K-State, other universities to study how climate affects plant evolution
10. New fruitfly model of diabetes has future implications for pancreatic cell transplantation
11. Pig-human transplantation not PERVerted

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Nation plant database falling behind survey shows

(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ... "Global Iris Recognition Market 2015-2019" report to ... Iris Recognition market to grow at a CAGR of ... report covers the present scenario and the growth prospects ... 2015-2019. To calculate the market size, the report considers ...
(Date:3/24/2015)... Fla. , March 24, 2015   ... management solutions, today announced that its U.are.U ® ... accessory retailer Goorin Bros . to achieve ... biometrics-based solution secures access to the POS terminal, ... increased risk of data breaches. ...
(Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
(Date:3/30/2015)... -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), a ... of innovative therapeutics addressing cancer and other unmet medical ... on China , announced today that ... the Company,s application to conduct a Phase 2 global ... for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)... 30, 2015    Intrexon Corporation (NYSE: ... and Merck Serono, the biopharmaceutical business of Merck ... announced an exclusive strategic collaboration and license agreement ... (CAR-T) cancer therapies. This collaboration advances Merck Serono,s ... modulate the immune system,s natural ability to fight ...
(Date:3/30/2015)... and BELLINGHAM, Washington, USA (PRWEB) March 29, 2015 ... in Europe and the United States and plenary talks ... planned for SPIE Optics + Optoelectronics next ... over 700 technical presentations in 17 conferences alongside a ... for optics and photonics , the event will run ...
(Date:3/30/2015)... 30, 2015  Naldemedine, an investigational peripherally acting ... & Co., Ltd., met its primary and secondary ... for the treatment of opioid-induced constipation (OIC) in ... therapy. Study results showed that naldemedine (0.2 mg ... frequency of spontaneous bowel movement (SBM) compared with ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3
Cached News: